www.fiercepharma.com Open in urlscan Pro
104.18.14.141  Public Scan

Form analysis
2 forms found in the DOM

GET /search-results

<form action="/search-results" method="get">
  <fieldset class="d-flex align-items-center position-relative input-search"><input type="text" placeholder="Search" name="fulltext_search" class="search-text w-100"><button class="search-submit d-flex align-items-center" id="header-search-submit"
      type="submit" aria-label="search"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="search" class="svg-inline--fa fa-search fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
        <path fill="currentColor"
          d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
        </path>
      </svg></button><input type="hidden" placeholder="Search" name="dns" value="fiercehealthcare_com,fiercebiotech_com,fiercepharma_com"></fieldset>
</form>

GET /search-results

<form class="w-100" action="/search-results" method="get">
  <fieldset class="d-flex justify-content-between position-relative input-search"><input type="text" placeholder="Search" name="fulltext_search" class="search-text w-100"><button class="search-submit d-flex align-items-center" id="search-submit"
      type="submit" aria-label="search"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="search" class="svg-inline--fa fa-search fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
        <path fill="currentColor"
          d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
        </path>
      </svg></button></fieldset>
</form>

Text Content

Fierce Pharma Continues Here ▼



Advertisement









 * Fierce Pharma
 * Fierce Biotech
 * Fierce Healthcare
 * Fierce Life Sciences Events

 * Advertise
 * About Us



 * Pharma
   
   * Vaccines
   * Asia
   * Cell & Gene Therapy
   * Drug Delivery
   * Executives
 * Manufacturing
   
   * Facilities
   * Recalls
   * Warning Letters
 * Marketing
 * Special Reports
 * Fierce 50
   
   * Special Report
   * Awards Gala

 * Resources
   
   * Podcasts
   * Fierce Events
   * Industry Events
   * Webinars
   * Whitepapers
   * Survey
 * Events
   
   
 * Subscribe

Subscribe

 * Pharma
   
   * Vaccines
   * Asia
   * Cell & Gene Therapy
   * Drug Delivery
   * Executives
 * Manufacturing
   
   * Facilities
   * Recalls
   * Warning Letters
 * Marketing
 * Special Reports
 * Fierce 50
   
   * Special Report
   * Awards Gala

 * Resources
   
   * Podcasts
   * Fierce Events
   * Industry Events
   * Webinars
   * Whitepapers
   * Survey
 * Events
   
   
 * Subscribe

 * Fierce Pharma
 * Fierce Biotech
 * Fierce Healthcare
 * Fierce Life Sciences Events

 * Advertise
 * About Us




Pharma


FDA'S AUTHORIZATION OF FLORIDA DRUG IMPORTATION PLAN DRAWS HEAT FROM US,
CANADIAN TRADE GROUPS

By Fraiser KansteinerJan 6, 2024 4:38pm
U.S. FDASupply ChainimportsCanada

Under the program, Florida says it will start providing drugs in a small number
of classes for patients with chronic health conditions such as HIV/AIDS, mental
illness, prostate cancer and urea cycle disorder. (Pixabay)

Florida has secured a major win in its yearslong quest to import cheaper drugs
from Canada—though the backlash from pharma trade groups on both sides of the
border has been swift and fierce.

The FDA on Friday authorized Florida’s drug importation program, which will be
valid for two years after the first shipment of medicines.







But before Florida can actually draw drugs down from the Great White North, the
state will need to submit medication-specific information for the FDA’s review
and approval, the regulator said in a press release.





Florida must also ensure that the drugs it seeks to import have been tested for,
among other things, authenticity and compliance with FDA standards. The imported
drugs will also need to be relabeled consistent with FDA regulations.

Florida will also be on the hook to submit a quarterly report to the FDA
detailing information about the imported drugs, cost savings and any potential
safety and quality issues, the FDA said.

While the FDA is willing to work with states on import programs, the proposals
“must demonstrate the programs would result in significant cost savings to
consumers without adding risk of exposure to unsafe or ineffective drugs,” FDA
Commissioner Robert Califf, M.D., stressed in a statement Friday.







The program could save Florida up to $180 million in the first year of full
operation, according to a release from the administration of the state’s
governor, Ron DeSantis.

Under the program, Florida says it will start providing drugs in a small number
of classes—including maintenance medications—for patients with chronic health
conditions like HIV/AIDS, mental illness, prostate cancer and urea cycle
disorder. 

The FDA’s authorization of the program represents the latest strike in a
sustained battle against high U.S. drug prices. Notably, Democrats passed the
Inflation Reduction Act in 2022, which will allow Medicare to negotiate prices
on select drugs beginning in 2026. Further, the law forces drugmakers to pay
rebates to Medicare if their prices rise faster than the rate of inflation.


RELATED

FDA clears more chemotherapy imports from China's Qilu amid shortage of key
cancer meds

Fierce JPM Week

LAST CHANCE TO REGISTER FOR FIERCE JPM WEEK 2024!

January 9-10, 2024

San Francisco, CA

Register

Still, industry representatives at home and abroad have been quick to strike
back against Governor DeSantis’ importation plan.

Innovative Medicines Canada (IMC), which represents major drugmakers in the
country, said it was “deeply concerned” by the FDA’s authorization.

“Canada simply can’t supply drugs to Florida, or any other U.S. states, without
significantly increasing the risk and severity of drug shortages nationwide,”
David Renwick, interim president of IMC, said in a statement.

The U.S. market is nearly 10 times bigger than Canada’s, Renwick pointed out,
warning the plan would “harm Canadian patients and disrupt our health-care
system.”


RELATED

In new lawsuit, Florida says FDA stalling on drug importation program

The reception hasn’t been much better in The States, where president and CEO of
the trade group the Pharmaceutical Researchers and Manufacturers of America
(PhRMA), Stephen Ubl, cautioned that the importation of unapproved medicines,
whether from Canada or elsewhere in the world, “poses a serious danger to public
health.”

PhRMA is considering “all options for preventing this policy from harming
patients," Ubl said.

U.S. FDASupply ChainimportsCanadaRobert Califfdrug
shortageshortagesHIV/AIDSprostate cancerManufacturing
Our Newsletter






RELATED ARTICLES

Climate change: What role does healthcare play?
Jan 22, 2024 08:00am
2023 Pharmacovigilance Industry Survey: Unveiling Transformation Trends
Jan 8, 2024 08:00am
Leading a New Era of Patient-Inspired Neuroscience
Jan 8, 2024 08:00am
After Pfizer's exit, UCB splits from industry trade group BIO
Jan 5, 2024 11:48am
See more articles
 * Connect
   
   * The Team
   * Advertise
 * Join Us
   
   * Newsletters
   * Resources
   * RSS Feeds
 * Our Brands
   
   * Fierce Biotech
   * Fierce Healthcare
   * Fierce Pharma
 * Our Events
   
   * Life Sciences Events

©2024 Questex LLC All rights reserved.
Terms of use
Privacy Policy



Close

In order to deliver a personalized and enhanced site navigation, we store
information on how you use the site. By continuing to use this site and access
its features, you are consenting to our use of cookies. For more information,
please see the Questex Privacy Policy.